A. P. Schulman-c and . Vaage-s, Tamsulosin, a selective a1c- adrenoreceptor antagonist: a randoInized controlled trial in patients with benign prostatic "obstruction" ( symptomatic BPH), Br J Drol, vol.3, pp.76-325, 1995.

A. P. Speakman-m, A. D. Stott-m, and . Pocock-r, A dose ranging study of the efficacy and safety of tamsulosin, the frrst prostateselective a1A-adrenoreceptor antagonist, in patients with benign prostatic obstruction ( symptomatic benign prostatic hyperplasia ), Br J Drol, vol.80, pp.587-596, 1997.

A. R. Ronstrom and . Lowhagen-t, Deferred treatment of clinically localized low grade prostate cancer: Experience from prospective series at Karolinska Hospital, J Urol, vol.152, pp.1757-1760, 1994.

A. , A. D. Bottomley-d, and C. B. , Short-term morbidity and acceptability of 1-125 implantation for localized carcinoma of the prostate, Br J Urol, vol.83, pp.53-56, 1999.

A. V. Hoekstra-c and L. H. , Variation in prostate position relative to adjacent bony anatomy, Int J Radiat Oncol Biol Phys, vol.34, pp.709-715, 1996.

A. R. Parsons-r and F. L. , Adenocarcinoma of the prostate treated with extemal-beam radiation therapy, Radiother Oncol, vol.18, pp.235-246, 1990.

A. V. and F. A. Dalmia-p, Quality of life after permanent prostate implant, Sernin Surg Oncol, vol.13, pp.461-464, 1997.

A. D. , F. A. Battermann, . De-reijke-t, . Lavagnini-p, and . Blank-l, ESTROIEAUIEORTC Recommendations on permanent seed implantation for localized prostate cancer, Radiother Oncol, vol.57, pp.315-321, 2000.

B. H. , T. S. , M. S. , Z. A. , A. G. De-reijke-t et al., Current status of minimally invasive treatment options for localized prostate carcinoma, Eur Urol, vol.37, pp.2-13, 2000.

B. R. Naslund-m and C. J. , A comparison of complications between ultrasound-guided prostate brachytherapy and open prostate brachytherapy, Int J Radiat One Biol Phys, vol.4, pp.47909-913, 2000.

B. K. Whittington-r and A. B. , Neoadjuvant androgen deprivation prior to Transperineal prostate brachytherapy, Cancer J Sei Am, vol.5, pp.370-373, 1999.

. C. Blasko-r, . Ragde-h, and . D. Grimm-p, Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications, Scand J Urol Nephrol, vol.137, pp.113-118, 1991.

. Blasko, Personal communication, 1997.

. Brandeis-lm, . S. Litwin-m, . Burnison-m, and . E. Reiter-r, QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER, The Journal of Urology, vol.163, issue.3, pp.851-857, 2000.
DOI : 10.1016/S0022-5347(05)67818-4

B. D. , C. A. Mlllef, R. Benoit-r, and C. J. Arshoun-y, Urinary morbidity with a modified peripheralloading technique of Transperineal 1-125 prostate implantation, Int J Radiat Oncol Biol Phys, issue.2, pp.47353-360, 2000.

. Buzelin, Urodynamique du bas appareil urinaire, 0200.

. Buzelin, Physiologie et explorations fonctionnelles de la voie excrétrice urinaire.-Paris : Editions Laboratoires Synthelabo, 1993.

C. D. Khoury-s, Interrogatoire du malade In: L'hypertrophie bénigne de la prostate, pp.69-71, 1991.

C. F. Belin-x, C. Y. Flam-t, and D. S. Paraf-f, Local staging of prostate cancer by endorectal MRI using fast spin-echo sequences: prospective correlation with pathological findings after radical prostatectomy, Br J Urol, vol.77, pp.843-850, 1996.

A. R. Brown-c, Pd-103 brachytherapy and external beam radiation therapy for clinically localized high risk prostatic carcinoma, Int J Radiat Oncol Biol Phys, vol.35, pp.875-879, 1996.

D. T. Shipley-w and . P. O-'leary-m, Preoperative irradiation and 125-1odine implantation for patients with localized carcinoma of the prostate, Int J Radiat Oncol Biol Phys, vol.5, pp.89-93, 1986.

S. R. Desai-r and . N. Stone-n, Acute urinary morbidity following I-125 interstitial implantation of the prostate gland, Radiation Oncology Investigations, vol.39, issue.3, pp.135-141, 1998.
DOI : 10.1016/0360-3016(94)90119-8

E. Din, K. E. , K. L. De, W. M. Debruyne-f, and R. C. De-la, Correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the international prostate symptom score, Urology, vol.3, pp.48-393, 1996.

E. C. Konety-b and . Narayan-p, Therapeutic strategies in stage A prostate cancer, Problems in Urology, vol.7, pp.137-150, 1993.

F. M. , G. D. Hehir-m, and K. R. , A review of radical prostatectomy from three centres in the UK, Br J Urol, vol.78, pp.911-920, 1996.

F. L. Barzell-w, . S. Hilaris-b, and . F. Whitmore-w, Complications for 1-125 iodine implantation in the treatment of prostatic cancer, J Urol, vol.121, pp.447-451, 1979.

F. F. , B. M. , L. , R. A. Wasson-l, and W. Le, Patient-reported complications and follow-up treatment after radical prostatectomy, Urology, vol.6, pp.42-622, 1993.

F. B. Bissonette-e and T. R. Peroni-g, Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma, Cancer, pp.912046-2055, 2001.

G. M. Fair-w, Historical perspective on prostate brachytherapy, JEndourol, vol.144, pp.315-318, 2000.

G. D. Potters-l, A. R. Waldbaum-r, W. X. , and L. S. , Urinary morbidity following ultrasound-guided transperineal prostate seed implantation, Int J Radiat Oncol Biol Phys, vol.1, pp.4559-67, 1999.

L. A. Golomb-r and . Siegel-y, Variability and Circadian Changes in Home Uroflowmetry in Patients with Benign Prostatic Hyperplasia Compared to Normal Controls, The Journal of Urology, vol.147, issue.4, pp.147-1044, 1992.
DOI : 10.1016/S0022-5347(17)37462-1

G. M. and S. W. Shulman-s, Cryosurgical treatment of the prostate, Invest Urol, vol.3, pp.372-378, 1966.

G. G. Larson-t, . S. Balch-c, . M. Grado-m, and . Collins-lm, Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance, Int J Radiat Oncol Biol Phys, vol.2, pp.42-289, 1998.

B. G. Hanlon-a, P. E. Schultheiss-i, . Movsas-b, and . E. Epstein-b, Dose escalation with 3D conformaI treatment: five year outcomes, treatment optimisation, and future directions, Int J Radiat Oncol Biol Phys, vol.41, pp.501-510, 1998.

H. P. Sobin-l, TNM Classification of malignant tumors, pp.141-144, 1992.

H. B. Bodner-w and M. C. , Brachytherapy: A historical perspective In: Radiotherapy of prostate cancer -The Netherlands, pp.255-259

H. K. Wallner-k, Urinary incontinence in patients who have a TURP/TUIP fol1owing prostate brachytherapy, Int J Radiat Oncol Biol Phys, vol.404, pp.783-786, 1998.

P. S. Laursen-f and . H. Holm-h, Ultrasonical1y guided 125-iodine seed implantation with external radiation in the management of localized prostatic carcinoma, Urology, vol.34, pp.181-186, 1989.

K. S. Chou-r, . K. Dodge-r, . W. Clough-r, . S. Kang-h, and . G. Bowen-m, Acute urinary toxicity fol1owing Transperineal prostate brachytherapy using a modified Quimby loading method, Int J Radiat Oncol Biol Phys, vol.4, pp.50-937, 2001.

K. K. Olson-d and . Payne, Detailed preliminary analysis of 1-125 implantation for localized prostate cancer using percutaneous approach, J Drol, vol.153, pp.1020-1025, 1995.

K. R. Bueschen-aj and . M. Salter-m, Retropubic iodine-125 seed implantation in the management of prostate cancer, Endocurietherapy/ Hyperthermie Oncol, vol.5, pp.141-146, 1989.

K. D. Kleinberg and R. J. Wallner-k, Logistic regression , statistics in the health science series, 1997.

A. V. Fuks-z and . Harrison-l, Treatment related symptoms during the first year fol1owing 1-125 prostate implantation, Int J Radiat Oncol Biol Phys, vol.28, pp.985-990, 1994.

K. B. Phelan-m, O. , D. W. , A. L. , and C. M. , Urolume stent placement for the treatment of postbrachytherapy bladder outlet obstruction, Urology, vol.55, pp.721-724, 2000.

K. C. Berkenstock-k, . M. Borofski-a, . Ziegler-ic, and B. A. Lightfoot-d, External beam irradiation versus 1-125 implant in the definitive treatment of prostatic carcinoma, Int J Radiat Oncol Biol Phys, vol.21, pp.955-960

K. T. Petroni-g and . A. Bossonnette-e, Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer, Urology, vol.55, pp.736-742, 2000.

K. P. Good-r, J. E. Bartone-ff, and . Lynch-g, Transperineal 1-125 endocurietherapy of prostate cancer, Am J Clin Oncol, pp.479-489, 1988.

K. Y. Kawabe-k and N. T. Honda-k, A pharmacological study of alpha-adrenergic receptor sub-types in smooth muscle of human urinary bladder and prostatic urethra, J Urol, vol.134, pp.396-398, 1985.

L. N. Wuu-c, B. R. Laguna-il, . E. Katz-a, . Bagiella-e, and . D. Ennis-r, Factors predicting for post-implantation urinary retention after permanent prostate brachytherapy, Int J Radiat Oncol Biol Phys, vol.5, pp.48-1457, 2000.

L. W. Mcquellon-r and C. L. , Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer, J Urol, vol.162, pp.403-406, 1999.

L. W. Mcquellon-r and H. K. , A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy for clinically localized prostate cancer, Iut J Radiat Oncol Biol Phys, vol.46, pp.77-81, 2000.

L. W. Mcquellon-r and . L. Mccullough-d, A prospective analysis of patient-reported quality of life after prostate brachytherapy, Sernin Urol Oncol, vol.18, issue.2, pp.147-151, 2000.

L. S. Heinmann-r, I: Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate, Iut J Radiat Oncol Biol Phys, p.26, 1993.

L. W. , F. S. , and W. H. Olsen-d, Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy, Iut J Radiat Oncol Biol Phys, vol.43, pp.735-778, 1999.

L. L. Albertsen-p, . Warren-r, and . Y. Siu-long, Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy, Urology, vol.54, pp.301-307, 1999.

L. D. , L. M. Henning-j, S. M. Flanders-s, and C. P. , Changes in health-related quality of life in the first year after treatment for prostate cancer, Urology, vol.531, pp.180-186, 1999.

M. Neill, S. A. Hargreave-t, . C. Geffriaud-ricouard, . Santon, and R. C. Ip, Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia, Urology, vol.57, pp.459-465, 2001.

M. H. , C. J. Aga-!-r, . Stenger-a, and . Esna-n, Comparison between two different 1-125 brachytherapy techniques: dosimetry preplanning (Seattle) or real-time (New-York) method, J Urol, issue.5, pp.165-322, 2001.

M. C. Jones-g and M. G. , Trends in prostate cancer in the D.S. 1974-1990, CA Cancer J Clin, pp.43-83, 1993.

M. C. , M. G. Mcdonald-c.-r, and M. H. , The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the D, S.. Cancer, vol.86, issue.9, pp.1877-1882, 1999.

M. R. Melzer-r, Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma, J Drol, vol.136, pp.422-424, 1986.

M. J. Peschel-r, rodine-125 implants versus extemal beam radiotherapy, Int J Radiat Oncol Biol Phys, vol.14, pp.1153-1157, 1988.

N. S. , S. D. Badalament-r, and S. A. , Transperineal Pd-l03 prostate brachytherapy. Analysis of morbidity and seed migration, Urology, vol.45, pp.87-92, 1995.

N. S. Beyer-d, F. J. Grimm-p, and . Nath-r, American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer, Int J Radiat Oncol Biol Phys, vol.44, pp.789-799, 1999.

N. S. Brce, W. K. De-wyngaert, P. B. Stock-r, and Y. Y. , The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis, Int J Radiat Oncol Biol Phys, vol.46, pp.221-230, 2000.

P. O. Degrais-p, Le traitement par radium du cancer de la prostate, J Drol, vol.4, pp.341-345, 1913.

P. C. Hanks-g and L. S. , Localized carcinoma of the prostate. Review of management with extemal beam radiation therapy, Cancer, vol.72, pp.3156-3173, 1993.

P. R. and C. Z. Roberts-k, Long-tenn complications with prostate implants, Radiat Oncol Investig, vol.7, pp.278-288, 1999.

P. B. Marinello-g, Manuel pratique de Curiethérapie - Paris : Hermann -1992

P. L. Von, E. A. , and S. S. , The efficacy and complications of salvage cryotherapy of the prostate, J Urol, vol.157, pp.921-925, 1997.

P. A. Forman, Prostate brachytherapy: an overview, Cancer, vol.71, issue.3, pp.953-957, 1993.

P. G. and J. A. Riddle-p, The accuracy ofultrasound in the measurement of changes in bladder volume, Br J Urol, p.55361, 1983.

P. B. and B. W. Kiefer-e, l: Timing of computed tomography-based postimplant assessment following permanent Transperineal prostate brachytherapy, Int J Radiat Oncol Biol Phys, vol.40, pp.1111-1115, 1998.

P. C. Beyer-d, Ultrasound-guided brachytherapy for treatment of confined prostate cancer, Urology, vol.40, pp.27-32, 1992.

J. E. and H. D. Landin-k, Interstitial 1-125 radiation without adjuvant therapy in the treatment of clinically localized prostate cancer, Cancer, vol.80, pp.442-453, 1997.

R. H. Blasko-r.-c, G. P. , K. G. Sylvester-le, and H. D. Cavanagh-w, Brachytherapy for clinically localized prostate cancer: results at 7 and 8 year follow-up, Sernin Surg Oncol, vol.13, pp.438-443, 1997.

A. A. Nadir-b, Ten-year disease free survival after transperineal sonography-guided iodine 125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma, Cancer, vol.83, pp.989-1001, 1998.

R. B. , M. W. , and W. Iw, I-125 implantation in localized prostate cancer, Endocurietherapy/ Hyperthennic Oncol, vol.6, pp.239-244, 1990.

S. P. , R. F. Botto-h, D. Teillac-p, . Ip, and . Boyle-p, Adaptation et validation en langue française du score international des symptômes de l'hypertrophie bénigne de la prostate, Prog Urol, vol.4, pp.532-540, 1994.

S. P. Whitmore-r, K. D. El-mahdi-a, and L. L. , Morbidity and mortality of local failure after definitive therapy for prostate cancer, J Drol, vol.141, pp.567-571, 1989.

S. D. Vadghan-e, W. J. Ciillng, M. , F. D. , and A. R. Knudsen-b, Bcl-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy, J Drol, vol.162, issue.1, pp.12-16, 1999.

S. D. Bosworth-j, . Potters-l, and S. J. Waldbaum-r, Complications of brachytherapy in 692 men treated for localized prostate cancer, J Dro!, issue.5, pp.159-65, 2000.

V. S. Speakman-m, Tamsulosin: 3-year long-tenn efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: analysis of a European, multinational, multicenter, openlabel study, Eur Drol, vol.36, pp.609-620, 1999.

S. R. Chovnick-s, B. R. , P. R. Othegdy-r, . Z. Solc, and C. A. Huff-w, Outpatient ultrasound-guided Palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients, Urology, vol.51, pp.796-803, 1998.

S. 1. Sdsset-ig, E. M. , and D. D. , Role of uroflowmetry in the assessment of lower urinary tract obstruction in adult males, Brit J Drol, pp.47-559, 1975.

S. M. Olsson-c, I: The flow rate nonnogram, J Drol, vol.122, pp.665-668, 1979.

S. D. , C. W. Steele-g, S. M. , S. D. , and Y. S. , The nature of prostate cancer detected through prostate specifie antigen based screening Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms, J Urol J Urol, vol.152, issue.164, pp.1732-1736, 1994.

S. S. , R. Id, A. Pw, C. J. Wuertzer-b, and . Kan-w, Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate, fut J Radiat Oncol Biol Phys, vol.37, pp.337-341, 1997.

S. N. Stock-r, Neoadjuvant hormonal therapy improves the outcomes of patients undergoing radioactive seed implantation for localized prostate cancer, Mol Urol, vol.3, issue.3, pp.239-244, 1999.

S. N. , R. P. Scardino-p, S. R. Khanna-o, and . F. Paulson-d, Ultrasound determination of prostate volume: comparison of transrectal and suprapubic methods, J Endourol, vol.5, pp.251-255, 1991.

S. N. and R. E. Stock-r, Prior transurethral resection does not increase morbidity following real-time ultrasound guided prostate seed implantation, Tech Urol, vol.6, pp.123-127, 2000.

S. M. , K. P. Amin-p, . C. Jacobs-s, and . Kyprianou-n, Apoptosis and bcl-2 expression in prostate cancer: significance in clinical outcome after brachytherapy, J Urol, vol.165, pp.2126-2130, 2001.

T. M. Gheiler-e and . Tiguert-r, Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer, Urology, vol.52, pp.224-229, 1998.

T. M. Stock-r and . N. Stone-n, Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate, J Urol, vol.160, pp.1379-1382, 1998.

T. M. Stamey-t, Determination of prostate volume by transrectal ultrasound, J Urol, vol.145, pp.984-989, 1991.

T. M. , C. R. Tempany-c, M. J. Kumar-s, . Schneider-l, . D. Hurwitz-m et al., Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy, Int J Radiat Oncol Biol Phys, vol.4, pp.47-905, 2000.

V. Pl, . H. Kurth-k, . E. Blank-l, . F. Dabhoiwala-n, . H. De-reijke-t et al., Treatment of localized prostatic carcinoma using a transrectal ultrasound guided Transperineal implantation technique, Eur Urol, vol.21, pp.35-41, 1992.

W. B. , I. R. De-la, R. J. , G. M. , and G. M. , The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction, J Urol, vol.165, pp.32-34, 2001.

W. H. , A. O. Stenwig-a, J. M. Tvera-k, and F. O. Pettersen-e, Desoxyribonucleic acid cytometry and histological findings before and after 125-Iodine implantation, J Urol, vol.148, pp.838-842, 1992.

W. T. , N. S. , and Y. D. Bahnson-r, Early voiding dysfunction associated with prostate brachytherapy, Urol Oncol, vol.6, issue.1, pp.20-23, 2001.

W. K. and L. H. Wasserman-s, Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection, Int J Radiat Oncol Biol Phys, vol.37, issue.3, pp.565-569, 1997.

W. F. Yue-n and R. S. , Effect of oedema on the post implant dosimetry of an 1-125 prostate implant, Int J Radiat Oncol Biol Phys, vol.38, pp.335-339, 1997.

W. T. Kandzari-s and . R. Jain-p, Iodine 125 seed implants for prostatic carcinoma, Urology, issue.2, pp.41-122, 1993.

W. W. Hilaris-b and G. H. , Retropubic implantation of iodine-125 in the treatment of prostatic carcinoma, J Urol, vol.108, p.918, 1972.

W. J. Wallner-k, Time-dependent changes in CT-based dosimetry of 1-125 prostate brachytherapy, Radiat Oncol Investig, vol.6, pp.157-160, 1998.

W. W. Chinn-d and T. W. Chinn-m, Cryosurgery as a treatment for prostate cancer, Cancer, vol.79, pp.963-974, 1997.

Z. S. , S. J. , R. A. Lederman-g, and A. P. , High dose combination radiotherapy for the treatment of localized prostate cancer, J Urol, vol.160, pp.91-96, 1998.

Z. M. Whitmore-w, Long-term results of retropubic permanent 125-iodine implantation of the prostate for clinically localized prostatic cancer, J Urol, vol.158, pp.23-30, 1997.

Z. M. Cowen-d and . Fuks-z, Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma, Cancer, vol.85, pp.2460-2468, 1999.

Z. M. Wallner-k and L. C. , Comparison of the 5- year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent rodine-125 implantation for early stage prostatic carcinoma, J Clin Oncol, vol.17, pp.517-522, 1999.